Physician profile
Summer Hess
NPI 1932731957
$2,098.40
in general payments reported to CMS, 2019-2025
17 companies · $1,542 in 2025
The $1,542 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $113 · 2022: $161 · 2023: $72.06 · 2024: $210 · 2025: $1,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,824.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $699.52 | 2021-2025 | Lifevest |
| Heartflow, INC. | $244.64 | 2025 | |
| Alnylam Pharmaceuticals INC. | $188.72 | 2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $162.49 | 2022-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $137.67 | 2025 | Verquvo, Winrevair, Capvaxive |
| Amgen INC. | $126.89 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $118.04 | 2022-2025 | |
| Novo Nordisk INC | $112.85 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.58 | 2025 | Jardiance |
| Boston Scientific Corporation | $54.39 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $39.33 | 2025 | Wainua |
| Pfizer INC. | $33.45 | 2021-2023 | |
| Insmed, INC. | $29.29 | 2023 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $23.77 | 2025 | Evkeeza |
| Daiichi Sankyo INC. | $20.73 | 2025 | Injectafer |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $17.06 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Summer Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.